Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gooley

Showing results (771-780 of 889) with videos related to

Pageof 89
Sort By:
Bone Marrow Transplantation|January 26, 2018
Biomarkers in chronic graft-versus-host disease: quo vadis?D Wolff, H Greinix, S J Lee, et al.
Cancer Research|June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell LymphomasShyril O'Steen, Damian J Green, Ajay K Gopal, et al.
Bone Marrow Transplantation|November 6, 2021
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulinAlbert C Yeh, Paul V O'Donnell, Gary Schoch, et al.
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
American Journal of Hematology|April 4, 2020
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphomaVictor A Chow, Joseph G Rajendran, Darrell R Fisher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine LymphomaShyril O'Steen, Sang Y Lee, Melissa L Comstock, et al.
Blood|May 17, 2003
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysisAjay K Gopal, Theodore A Gooley, David G Maloney, et al.
Blood|February 20, 2025
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host diseaseJulie R Boiko, Kathleen S Ensbey, Olivia G Waltner, et al.
Chronobiology International|April 19, 2016
Circadian gene variants influence sleep and the sleep electroencephalogram in humansAnne-Marie Chang, Andrew C Bjonnes, Daniel Aeschbach, et al.
Blood|July 1, 2004
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningFrédéric Baron, Jennifer E Baker, Rainer Storb, et al.
Pageof 89

Showing results (771-780 of 889) with videos related to

Sort By:
Pageof 89
Bone Marrow Transplantation|January 26, 2018
Biomarkers in chronic graft-versus-host disease: quo vadis?D Wolff, H Greinix, S J Lee, et al.
Cancer Research|June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell LymphomasShyril O'Steen, Damian J Green, Ajay K Gopal, et al.
Bone Marrow Transplantation|November 6, 2021
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulinAlbert C Yeh, Paul V O'Donnell, Gary Schoch, et al.
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
American Journal of Hematology|April 4, 2020
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphomaVictor A Chow, Joseph G Rajendran, Darrell R Fisher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine LymphomaShyril O'Steen, Sang Y Lee, Melissa L Comstock, et al.
Blood|May 17, 2003
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysisAjay K Gopal, Theodore A Gooley, David G Maloney, et al.
Blood|February 20, 2025
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host diseaseJulie R Boiko, Kathleen S Ensbey, Olivia G Waltner, et al.
Chronobiology International|April 19, 2016
Circadian gene variants influence sleep and the sleep electroencephalogram in humansAnne-Marie Chang, Andrew C Bjonnes, Daniel Aeschbach, et al.
Blood|July 1, 2004
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningFrédéric Baron, Jennifer E Baker, Rainer Storb, et al.
Pageof 89